share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP:信函
美股sec公告 ·  04/22 13:23
Moomoo AI 已提取核心信息
Apollomics Inc., a biopharmaceutical company, has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3 to April 24, 2024. The request, filed via EDGAR and dated April 22, 2024, follows the initial filing of the Registration Statement on April 1, 2024. The company seeks to have the Registration Statement, which pertains to the registration of securities for potential future offerings, declared effective at 5:00 p.m. Washington, D.C. time on the requested date or as soon as possible thereafter. Apollomics has designated Daniel Nussen of White & Case LLP as the contact person for any inquiries from the SEC and to receive notification upon the acceleration approval.
Apollomics Inc., a biopharmaceutical company, has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3 to April 24, 2024. The request, filed via EDGAR and dated April 22, 2024, follows the initial filing of the Registration Statement on April 1, 2024. The company seeks to have the Registration Statement, which pertains to the registration of securities for potential future offerings, declared effective at 5:00 p.m. Washington, D.C. time on the requested date or as soon as possible thereafter. Apollomics has designated Daniel Nussen of White & Case LLP as the contact person for any inquiries from the SEC and to receive notification upon the acceleration approval.
生物制药公司Apollomics Inc. 已正式要求美国证券交易委员会(SEC)将其F-3表格注册声明的生效日期加快至2024年4月24日。该申请是在2024年4月1日首次提交注册声明之后通过EDGAR提交的,日期为2024年4月22日。该公司希望在要求的日期华盛顿特区时间下午 5:00 宣布与未来可能发行的证券注册有关的注册声明生效,或在此之后尽快宣布生效。Apollomics已指定White & Case LLP的丹尼尔·努森为美国证券交易委员会任何询问的联系人,并在加速批准后接收通知。
生物制药公司Apollomics Inc. 已正式要求美国证券交易委员会(SEC)将其F-3表格注册声明的生效日期加快至2024年4月24日。该申请是在2024年4月1日首次提交注册声明之后通过EDGAR提交的,日期为2024年4月22日。该公司希望在要求的日期华盛顿特区时间下午 5:00 宣布与未来可能发行的证券注册有关的注册声明生效,或在此之后尽快宣布生效。Apollomics已指定White & Case LLP的丹尼尔·努森为美国证券交易委员会任何询问的联系人,并在加速批准后接收通知。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息